Panacea Biotec Share Price

Small Cap | Pharmaceuticals and health care | NSE: PANACEABIO | BSE: 531349

₹323.55 image-19.60 (-5.71 %)

Last Updated: 21 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 338.25

High (₹) 348.50

Low (₹) 321.00

Prev. Close (₹) 343.15

Volume 15,031

VWAP (₹) 332.42

ROCE (%) -3.32

Industry P/E 43.99

TTM P/E -250.81

P/B Ratio 2.42

Market Cap (₹) Cr.1,984.52

Dividend Yield (%)--

EPS (₹) -0.19

ROE-0.14%

Sales Growth (%) 21.57

Profit Growth (%)-95.54

Day Range

348.50348.50

L
H

52 Week Range

112.70489.00

L
H

Historical Returns

Returns (6M)

35.63 %

Returns (1Y)

99.72 %

Returns (3Y)

64.87 %

Returns (5Y)

185.07 %

Returns (6M)

35.63 %

Returns (1Y)

99.72 %

Returns (3Y)

64.87 %

Returns (5Y)

185.07 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with Low Debt
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 44.10

MFI 50.30

ATR 31.18

Commodity Channel Index -67.43

ROC125 62.14

ROC21 -10.89

Williams %R -90.40

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current341.04358.52368.54331.02313.54303.52286.04
Week Ago349.64361.77376.24335.17323.04308.57296.44
Month Ago449.61475.78488.86436.53410.36397.28371.11

EMA & SMA
info_icon

323.55

Current Price

EMA & SMApin

Bullish Moving Averages

2

Bearish Moving Averages

18

5 Day 337.53


9 Day 342.31


10 Day 353.52


12 Day 364.33


14 Day 362.25

20 Day 351.25


26 Day 369.06


50 Day 402.66


100 Day 379.57


200 Day 276.74

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ADAR CYRUS POONAWALLA .blockSell17 May, 2021₹373.8531,57,034BSE
SERUM INSTITUTE OF INDIA PRIVATE LIMITEDblockBuy17 May, 2021₹373.8531,57,034BSE
ADAR CYRUS POONAWALLA .bulkSell17 May, 2021₹373.8531,57,034BSE
SERUM INSTITUTE OF INDIA PRIVATE LIMITEDbulkBuy17 May, 2021₹373.8531,57,034BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
02 Jan, 2025Sandeep JainDisposal₹409.0655,000BSE
31 Dec, 2024Sandeep JainDisposal₹425.044310,000BSE
30 Dec, 2024Rajesh JainAcquisition₹454.903,000BSE
25 Dec, 2024Sandeep JainDisposal₹426.23165,000BSE
25 Dec, 2024Sandeep JainDisposal₹439.551710,000BSE
20 Dec, 2024Sandeep JainDisposal₹450.88665,000BSE
20 Dec, 2024Sandeep JainDisposal₹455.325,700BSE
17 Dec, 2024Sandeep JainDisposal₹485.0885,500BSE
17 Dec, 2024Sandeep JainDisposal₹470.775363636363636363636363611,000BSE
12 Dec, 2024Sandeep JainDisposal₹464.15272727272727272727272735,500BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
15 Feb, 2025NSE IndiaPanacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication w.r.t. extract of Statement of Unaudited Financial Results for the quarter and nine months ended 31.12.2024, published in the newspapers on February 15, 2025
15 Feb, 2025BSE IndiaPlease find attached disclosure regarding appointment / re-appointment of Directors
14 Feb, 2025NSE IndiaPanacea Biotec Limited has informed the Exchange regarding Change in Director(s) of the company.
14 Feb, 2025NSE IndiaPANACEA BIOTEC LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
14 Feb, 2025BSE IndiaIntegrated Filing (Financial) for the quarter ended December 31, 2024.
14 Feb, 2025NSE IndiaIntegrated Filing (Financial) for the quarter ended December 31, 2024
14 Feb, 2025NSE IndiaPanacea Biotec Limited has informed the Exchange about change in Management
14 Feb, 2025BSE IndiaPlease find attached disclosures regarding appointment / re-appointment of directors and change in Senior Management Personnel
14 Feb, 2025BSE IndiaThe Board of Directors in its meeting held today i.e. 14.02.2025, inter-alia, considered and approved the unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2024.\r\n\r\nThe said results are enclosed herewith as annexure.
14 Feb, 2025NSE IndiaPanacea Biotec Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--01 Feb, 202514 Feb, 2025
Quarterly Results--31 Oct, 202413 Nov, 2024
Quarterly Results--05 Aug, 202414 Aug, 2024
Audited Results--14 May, 202430 May, 2024
Quarterly Results--31 Jan, 202413 Feb, 2024
Quarterly Results--25 Oct, 202310 Nov, 2023
Quarterly Results--02 Aug, 202312 Aug, 2023
Audited Results--16 May, 202330 May, 2023
Quarterly Results--03 Feb, 202314 Feb, 2023
Quarterly Results--07 Nov, 202214 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Panacea Biotec

Panacea Biotec is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 359.60 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Not Applicable

Founded

1984

Managing Director

Dr. Rajesh Jain

NSE Symbol

PANACEABIO

Panacea Biotec Management

NameDesignation
Dr. Rajesh JainChairman & Managing Director
Mr. Sandeep JainJoint Managing Director
Mr. Ankesh JainWhole Time Director
Mrs. Ambika SharmaNon Executive Director
Mr. N N KhamitkarNon Executive Director
Mr. Mukul GuptaNon Executive Director
Mr. Narotam Kumar JunejaNon Executive Director
Mr. K M LalNon Executive Director
Mrs. Manjula UpadhyayNon Executive Director
Mr. Bhupinder SinghNon Executive Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,643.75 image
₹1,669.30(-1.53%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,757.05 image
₹5,978.30(-3.70%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,475.75 image
₹1,479.70(-0.27%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,327.75 image
₹2,348.45(-0.88%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,151.80 image
₹1,170.95(-1.64%)
₹1,104.690 - ₹1,420.200

FAQs on Panacea Biotec

What is the share price of Panacea Biotec?

The share price of Panacea Biotec on 21 Feb, 2025 is ₹ 323.55.

What is 52W high and 52W low share price of Panacea Biotec?

The highest and lowest 52W share prices of Panacea Biotec are ₹ 489.000 and ₹ 112.700

What is the market cap of Panacea Biotec?

The market capitalization of Panacea Biotec as of 21 Feb, 2025 is ₹ 1,984.52 Crores

What is the P/E ratio of Panacea Biotec?

The current P/E ratio of Panacea Biotec as of 21 Feb, 2025 is 43.99

What is the PB ratio of Panacea Biotec?

The PB ratio of Panacea Biotec as of 21 Feb, 2025 is 2.42

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited